Barclays
CYTR

Barclays’s CytRx Corp CYTR Stock Holding History

Barclays’s Portfolio CYTR Stock Details CYTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-3
Closed – – 7631
2018
Q1 		$0 Buy
3
+1
+50% +$2 ﹤0.01% 7648
2017
Q4 		$0 Hold
2
– – ﹤0.01% 7372
2017
Q3 		$0 Sell
2
-11,322
-100% -$38.3K ﹤0.01% 7317
2017
Q2 		$43K Sell
11,324
-366
-3% -$1.25K ﹤0.01% 5446
2017
Q1 		$31K Buy
11,690
+11,386
+3,745% +$28.8K ﹤0.01% 5603
2016
Q4 		$1K Buy
304
+203
+201% +$597 ﹤0.01% 6560
2016
Q3 		$0 Buy
+101
New +$463 ﹤0.01% 7083
2015
Q4 		– Sell
-58
Closed -$1K – 7259
2015
Q3 		$1K Sell
58
-120
-67% -$2.03K ﹤0.01% 6772
2015
Q2 		$3K Sell
178
-105
-37% -$2.63K ﹤0.01% 6763
2015
Q1 		$5K Sell
283
-247
-47% -$4.6K ﹤0.01% 6658
2014
Q4 		$6K Sell
530
-615
-54% -$9.59K ﹤0.01% 6963
2014
Q3 		$13K Buy
1,145
+924
+418% +$18.3K ﹤0.01% 6765
2014
Q2 		$5K Buy
221
+206
+1,373% +$4.7K ﹤0.01% 7161
2014
Q1 		$0 Sell
15
-6,217
-100% -$221K ﹤0.01% 7984
2013
Q4 		$224K Buy
+6,232
New +$113K ﹤0.01% 4896

Other funds holding CYTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Barclays's CYTR Position: Q2 2018 in Review

Barclays sold out of CytRx Corp (CYTR) in Q2 2018, closing a stake of 3 shares.

Barclays first reported a position in CYTR in Q4 2013 and held it in 15 quarters. The position peaked at $224K in Q4 2013. 38 funds tracked by Wall St. Rank hold CYTR as of Q2 2018.

  • Barclays reported no remaining CytRx Corp position as of Q2 2018 after selling out during the quarter.
  • Barclays sold 3 CytRx Corp shares in Q2 2018.
  • Barclays first reported a position in CytRx Corp in Q4 2013 and held it in 15 quarters.
  • Barclays's CytRx Corp position peaked at $224K in Q4 2013.
  • 38 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2018.

Based on Barclays's 13F filing for Q2 2018, filed 14 Aug 2018.